News
Ognomy Sleep Raises $20M Series A to Expand Virtual Sleep Apnea Care
Overview
Ognomy Sleep, a leading virtual sleep medicine platform transforming access to diagnosis and treatment for obstructive sleep apnea, announced the closing of a $20 million Series A financing round led by Catalyst Investors, with participation from Blue Heron Capital. The round also included new and follow-on investments from Impellent Ventures, LaunchNY, Excell and Upstate Biotech Ventures, University of Buffalo, and strategic partners who have supported the company’s growth and mission since its early stages
The Big Picture
Recognized by the 2026 MedTech Breakthrough Award for Best Overall SleepTech Solution, Ognomy has logged 85,000+ virtual visits across all 50 states.
“Sleep apnea affects more than one billion people globally. This financing marks a milestone in our mission to fundamentally reimagine how sleep medicine is delivered.” -Daniel Rifkin, MD, MPH, Founder & CEO, Ognomy Sleep
